RU2001129098A - Compounds and methods for treating asthma, allergies and inflammatory disorders - Google Patents
Compounds and methods for treating asthma, allergies and inflammatory disordersInfo
- Publication number
- RU2001129098A RU2001129098A RU2001129098/04A RU2001129098A RU2001129098A RU 2001129098 A RU2001129098 A RU 2001129098A RU 2001129098/04 A RU2001129098/04 A RU 2001129098/04A RU 2001129098 A RU2001129098 A RU 2001129098A RU 2001129098 A RU2001129098 A RU 2001129098A
- Authority
- RU
- Russia
- Prior art keywords
- piperazinyl
- chlorophenyl
- ethoxy
- phenylmethyl
- phenyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims 24
- 208000006673 Asthma Diseases 0.000 title claims 3
- 206010020751 Hypersensitivity Diseases 0.000 title 1
- 200000000018 inflammatory disease Diseases 0.000 title 1
- -1 N - {[3- (2- {4 - [(1R) (4-chlorophenyl) phenylmethyl] piperazinyl} ethoxy) phenyl] methyl} (methyl (hydroxyamino)) carboxyamide Chemical compound 0.000 claims 34
- 229910052739 hydrogen Inorganic materials 0.000 claims 21
- 239000001257 hydrogen Substances 0.000 claims 21
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 19
- 125000002947 alkylene group Chemical group 0.000 claims 16
- 125000004419 alkynylene group Chemical group 0.000 claims 14
- 150000002431 hydrogen Chemical class 0.000 claims 13
- 125000004450 alkenylene group Chemical group 0.000 claims 12
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 claims 10
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 229910052736 halogen Inorganic materials 0.000 claims 9
- 150000002367 halogens Chemical class 0.000 claims 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 9
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 claims 7
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 7
- 125000005936 piperidyl group Chemical group 0.000 claims 7
- 125000004193 piperazinyl group Chemical group 0.000 claims 6
- 125000001424 substituent group Chemical group 0.000 claims 6
- 125000001309 chloro group Chemical group Cl* 0.000 claims 5
- 150000002390 heteroarenes Chemical class 0.000 claims 5
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 4
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 4
- 241001120493 Arene Species 0.000 claims 4
- 239000005711 Benzoic acid Substances 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 4
- 125000000304 alkynyl group Chemical group 0.000 claims 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims 4
- 235000010233 benzoic acid Nutrition 0.000 claims 4
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-M benzoate Chemical compound [O-]C(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-M 0.000 claims 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 3
- 150000001768 cations Chemical class 0.000 claims 3
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- 125000001989 1,3-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([H])C([*:2])=C1[H] 0.000 claims 2
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- BJQVFHKPGQLGGH-WJOKGBTCSA-N 4-[3-acetamido-4-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]phenyl]but-3-ynyl-aminocarbamic acid Chemical compound CC(=O)NC1=CC(C#CCCN(N)C(O)=O)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 BJQVFHKPGQLGGH-WJOKGBTCSA-N 0.000 claims 2
- HVFWZQHRSRUOFV-UHFFFAOYSA-N C1=CC(C#CCC[N-]ON)=CC=C1OCCCCN1CCN(C(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 Chemical compound C1=CC(C#CCC[N-]ON)=CC=C1OCCCCN1CCN(C(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 HVFWZQHRSRUOFV-UHFFFAOYSA-N 0.000 claims 2
- PXONIJSAAQWUPQ-SSEXGKCCSA-N C1=CC(C#CCC[N-]ON)=CC=C1OCCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 Chemical compound C1=CC(C#CCC[N-]ON)=CC=C1OCCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 PXONIJSAAQWUPQ-SSEXGKCCSA-N 0.000 claims 2
- ZFEVHRMIJUMXSY-WJOKGBTCSA-N ClC1=CC=C(C=C1)[C@H](N1CCN(CC1)CCCCOC1=CC=C(C=C1)CCCC[N-]ON)C1=CC=CC=C1 Chemical compound ClC1=CC=C(C=C1)[C@H](N1CCN(CC1)CCCCOC1=CC=C(C=C1)CCCC[N-]ON)C1=CC=CC=C1 ZFEVHRMIJUMXSY-WJOKGBTCSA-N 0.000 claims 2
- AZNRWZIVKQFIOE-GDLZYMKVSA-N FC(F)(F)C1=CC(C#CCC[N-]ON)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 Chemical compound FC(F)(F)C1=CC(C#CCC[N-]ON)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 AZNRWZIVKQFIOE-GDLZYMKVSA-N 0.000 claims 2
- HYKFENQEHVJERY-UODIDJSMSA-N O1[C@H](C#CCC[N-]ON)CC[C@H]1CN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 Chemical compound O1[C@H](C#CCC[N-]ON)CC[C@H]1CN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 HYKFENQEHVJERY-UODIDJSMSA-N 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 2
- 125000004849 alkoxymethyl group Chemical group 0.000 claims 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 2
- 230000001684 chronic Effects 0.000 claims 2
- 125000005842 heteroatoms Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 229960001340 histamine Drugs 0.000 claims 2
- 150000002617 leukotrienes Chemical class 0.000 claims 2
- 125000004430 oxygen atoms Chemical group O* 0.000 claims 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- ZEQOXEWIRZODSP-NDESMUNGSA-N (E)-3-[5-[4-[amino(carboxy)amino]but-1-ynyl]-2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]phenyl]prop-2-enoic acid Chemical compound OC(=O)/C=C/C1=CC(C#CCCN(N)C(O)=O)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 ZEQOXEWIRZODSP-NDESMUNGSA-N 0.000 claims 1
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 claims 1
- MKEOWPFZNUZZKL-GDLZYMKVSA-N 1-[3-[4-[3-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]propyl]phenoxy]propyl]-1-hydroxyurea Chemical compound C1=CC(OCCCN(O)C(=O)N)=CC=C1CCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 MKEOWPFZNUZZKL-GDLZYMKVSA-N 0.000 claims 1
- QCLCIWVXAHNWLS-GDLZYMKVSA-N 1-[4-[4-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]-2-nitrophenyl]but-3-ynyl]-1-hydroxyurea Chemical compound C1=C([N+]([O-])=O)C(C#CCCN(O)C(=O)N)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 QCLCIWVXAHNWLS-GDLZYMKVSA-N 0.000 claims 1
- DAVMXYWJTSAYLD-UHFFFAOYSA-N 1-[4-[4-[2-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]ethoxy]-2-nitrophenyl]but-3-ynyl]-1-hydroxyurea Chemical compound C1=C([N+]([O-])=O)C(C#CCCN(O)C(=O)N)=CC=C1OCCN1CCN(C(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 DAVMXYWJTSAYLD-UHFFFAOYSA-N 0.000 claims 1
- VDFNKKXMZTVILJ-UHFFFAOYSA-N 5-[4-[amino(carboxy)amino]but-1-ynyl]-2-[2-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]ethoxy]benzoic acid Chemical compound OC(=O)C1=CC(C#CCCN(N)C(O)=O)=CC=C1OCCN1CCN(C(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 VDFNKKXMZTVILJ-UHFFFAOYSA-N 0.000 claims 1
- KHVLZYHEWIBDOU-GDLZYMKVSA-N 5-[4-[carbamoyl(hydroxy)amino]but-1-ynyl]-2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]benzamide Chemical compound NC(=O)C1=CC(C#CCCN(O)C(=O)N)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 KHVLZYHEWIBDOU-GDLZYMKVSA-N 0.000 claims 1
- FBICXVRJYTUMQZ-GDLZYMKVSA-N 5-[4-[carbamoyl(hydroxy)amino]butyl]-2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]benzamide Chemical compound NC(=O)C1=CC(CCCCN(O)C(=O)N)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 FBICXVRJYTUMQZ-GDLZYMKVSA-N 0.000 claims 1
- BQRZGSFINHWZJE-UHFFFAOYSA-N C1=CC(C#CCC[N-]ON)=CC=C1OCCCN1CCN(C(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 Chemical compound C1=CC(C#CCC[N-]ON)=CC=C1OCCCN1CCN(C(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 BQRZGSFINHWZJE-UHFFFAOYSA-N 0.000 claims 1
- VUGGGUDBPDXAHO-GDLZYMKVSA-N C1=CC(C#CCC[N-]ON)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 Chemical compound C1=CC(C#CCC[N-]ON)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 VUGGGUDBPDXAHO-GDLZYMKVSA-N 0.000 claims 1
- YTAJFKXNMPWVJR-GDLZYMKVSA-N C1=CC(CCCC[N-]ON)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 Chemical class C1=CC(CCCC[N-]ON)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 YTAJFKXNMPWVJR-GDLZYMKVSA-N 0.000 claims 1
- AWMNLYPABSEKRW-UHFFFAOYSA-N C1=CC(CC[N-]ON)=CC=C1OCCN1CCN(C(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 Chemical compound C1=CC(CC[N-]ON)=CC=C1OCCN1CCN(C(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)CC1 AWMNLYPABSEKRW-UHFFFAOYSA-N 0.000 claims 1
- JYUPLOIAKANENW-HHHXNRCGSA-N C1=CC(C[N-]ON)=CC=C1CCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 Chemical compound C1=CC(C[N-]ON)=CC=C1CCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 JYUPLOIAKANENW-HHHXNRCGSA-N 0.000 claims 1
- JLRLNXUFEZSYGO-AREMUKBSSA-N C1=CC(C[N-]ON)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 Chemical compound C1=CC(C[N-]ON)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 JLRLNXUFEZSYGO-AREMUKBSSA-N 0.000 claims 1
- WPHUELZXTHHLHI-LJAQVGFWSA-N ClC1=CC=C(C=C1)[C@@H](N1CCN(CC1)CCOC1=C(C=C(C=C1)CCCC[N-]ON)C(F)(F)F)C1=CC=CC=C1 Chemical compound ClC1=CC=C(C=C1)[C@@H](N1CCN(CC1)CCOC1=C(C=C(C=C1)CCCC[N-]ON)C(F)(F)F)C1=CC=CC=C1 WPHUELZXTHHLHI-LJAQVGFWSA-N 0.000 claims 1
- IZZQMDUPZCPKQM-WJOKGBTCSA-N ClC1=CC=C(C=C1)[C@H](N1CCN(CC1)CCCCOC1=CC=C(C=C1)C#CCC[N-]ON)C1=CC=CC=C1 Chemical compound ClC1=CC=C(C=C1)[C@H](N1CCN(CC1)CCCCOC1=CC=C(C=C1)C#CCC[N-]ON)C1=CC=CC=C1 IZZQMDUPZCPKQM-WJOKGBTCSA-N 0.000 claims 1
- UXADFPLSPPGUNZ-SSEXGKCCSA-N ClC1=CC=C(C=C1)[C@H](N1CCN(CC1)CCCOC1=CC=C(C=C1)CCCC[N-]ON)C1=CC=CC=C1 Chemical compound ClC1=CC=C(C=C1)[C@H](N1CCN(CC1)CCCOC1=CC=C(C=C1)CCCC[N-]ON)C1=CC=CC=C1 UXADFPLSPPGUNZ-SSEXGKCCSA-N 0.000 claims 1
- XIVMVVSDYWZALU-GDLZYMKVSA-N ClC1=CC=C(C=C1)[C@H](N1CCN(CC1)CCCOC1=CC=C(C=C1)CCC[N-]ON)C1=CC=CC=C1 Chemical compound ClC1=CC=C(C=C1)[C@H](N1CCN(CC1)CCCOC1=CC=C(C=C1)CCC[N-]ON)C1=CC=CC=C1 XIVMVVSDYWZALU-GDLZYMKVSA-N 0.000 claims 1
- WPHUELZXTHHLHI-GDLZYMKVSA-N ClC1=CC=C(C=C1)[C@H](N1CCN(CC1)CCOC1=C(C=C(C=C1)CCCC[N-]ON)C(F)(F)F)C1=CC=CC=C1 Chemical compound ClC1=CC=C(C=C1)[C@H](N1CCN(CC1)CCOC1=C(C=C(C=C1)CCCC[N-]ON)C(F)(F)F)C1=CC=CC=C1 WPHUELZXTHHLHI-GDLZYMKVSA-N 0.000 claims 1
- JKMYFLKYGIOPKD-GDLZYMKVSA-N ClC1=CC=C(C=C1)[C@H](N1CCN(CC1)CCOC=1C=C(C=CC=1)C#CCC[N-]ON)C1=CC=CC=C1 Chemical compound ClC1=CC=C(C=C1)[C@H](N1CCN(CC1)CCOC=1C=C(C=CC=1)C#CCC[N-]ON)C1=CC=CC=C1 JKMYFLKYGIOPKD-GDLZYMKVSA-N 0.000 claims 1
- 206010010741 Conjunctivitis Diseases 0.000 claims 1
- 208000005679 Eczema Diseases 0.000 claims 1
- AFPFAMXQSOWBBF-GDLZYMKVSA-N FC1=CC(C#CCC[N-]ON)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 Chemical compound FC1=CC(C#CCC[N-]ON)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 AFPFAMXQSOWBBF-GDLZYMKVSA-N 0.000 claims 1
- 208000004262 Food Hypersensitivity Diseases 0.000 claims 1
- 206010021972 Inflammatory bowel disease Diseases 0.000 claims 1
- 210000004072 Lung Anatomy 0.000 claims 1
- 230000036740 Metabolism Effects 0.000 claims 1
- QEOUURNPMZIUFI-AREMUKBSSA-N NO[N-]CC1=CC=CC(OCCN2CCN(CC2)[C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 Chemical compound NO[N-]CC1=CC=CC(OCCN2CCN(CC2)[C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 QEOUURNPMZIUFI-AREMUKBSSA-N 0.000 claims 1
- TYCAQJMCRFXFIP-GDLZYMKVSA-N NO[N-]CCCCC1=CC=CC(OCCN2CCN(CC2)[C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 Chemical compound NO[N-]CCCCC1=CC=CC(OCCN2CCN(CC2)[C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)=C1 TYCAQJMCRFXFIP-GDLZYMKVSA-N 0.000 claims 1
- TUSXSALXSWDVPQ-NBXNUCLWSA-N O1C(C#CC([N-]ON)C)=CC=C1CN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 Chemical compound O1C(C#CC([N-]ON)C)=CC=C1CN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 TUSXSALXSWDVPQ-NBXNUCLWSA-N 0.000 claims 1
- 206010033078 Otitis media Diseases 0.000 claims 1
- 208000005374 Poisoning Diseases 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 claims 1
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims 1
- 206010039083 Rhinitis Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 206010039095 Rhinitis seasonal Diseases 0.000 claims 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L Sulphite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 claims 1
- 208000007536 Thrombosis Diseases 0.000 claims 1
- 206010046736 Urticarias Diseases 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004948 alkyl aryl alkyl group Chemical group 0.000 claims 1
- 125000002877 alkyl aryl group Chemical group 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 150000001449 anionic compounds Chemical class 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 230000031018 biological processes and functions Effects 0.000 claims 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 201000009151 chronic rhinitis Diseases 0.000 claims 1
- 201000004624 dermatitis Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 231100001003 eczema Toxicity 0.000 claims 1
- SGDMQKSRAZTFKR-WJOKGBTCSA-N ethyl N-[4-[4-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]phenyl]but-3-ynyl]-N-hydroxycarbamate Chemical compound C1=CC(C#CCCN(O)C(=O)OCC)=CC=C1OCCN1CCN([C@H](C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 SGDMQKSRAZTFKR-WJOKGBTCSA-N 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 235000020932 food allergy Nutrition 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 229910001412 inorganic anion Inorganic materials 0.000 claims 1
- 230000001404 mediated Effects 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 claims 1
- 230000035786 metabolism Effects 0.000 claims 1
- 230000000414 obstructive Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 230000000607 poisoning Effects 0.000 claims 1
- 231100000572 poisoning Toxicity 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 201000004681 psoriasis Diseases 0.000 claims 1
- 230000001932 seasonal Effects 0.000 claims 1
- 201000009890 sinusitis Diseases 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 125000004434 sulfur atoms Chemical group 0.000 claims 1
Claims (24)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12652199P | 1999-03-26 | 1999-03-26 | |
US60/126,521 | 1999-03-26 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2004122075/04A Division RU2004122075A (en) | 2004-07-21 | 2004-07-21 | N- (3-BUTIN-IL) -N-HYDROXYCHEMIA |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001129098A true RU2001129098A (en) | 2003-08-27 |
RU2241707C2 RU2241707C2 (en) | 2004-12-10 |
Family
ID=22425273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001129098/04A RU2241707C2 (en) | 1999-03-26 | 2000-03-23 | 1,4-substituted piperazines or 4-alkylidenyl piperidines, pharmaceutical composition based on thereof and method for treatment |
Country Status (37)
Country | Link |
---|---|
US (3) | US6451801B1 (en) |
EP (1) | EP1165533B1 (en) |
JP (2) | JP2002540198A (en) |
KR (1) | KR20020005635A (en) |
CN (3) | CN1528742A (en) |
AR (2) | AR020026A1 (en) |
AT (1) | ATE279401T1 (en) |
AU (1) | AU761422B2 (en) |
BG (1) | BG105909A (en) |
BR (1) | BR0009341A (en) |
CA (1) | CA2368090A1 (en) |
CO (1) | CO5180543A1 (en) |
CZ (1) | CZ20013471A3 (en) |
DE (1) | DE60014876T2 (en) |
DZ (1) | DZ3027A1 (en) |
EE (2) | EE200400104A (en) |
ES (1) | ES2231164T3 (en) |
GT (1) | GT200000034A (en) |
HK (1) | HK1041880B (en) |
HU (1) | HUP0200613A2 (en) |
ID (1) | ID30430A (en) |
IL (1) | IL145481A0 (en) |
IS (2) | IS6077A (en) |
JO (1) | JO2250B1 (en) |
MX (1) | MXPA01009664A (en) |
NO (2) | NO20014648L (en) |
NZ (1) | NZ514291A (en) |
PA (1) | PA8493101A1 (en) |
PE (1) | PE20001566A1 (en) |
PL (1) | PL350845A1 (en) |
RU (1) | RU2241707C2 (en) |
SK (1) | SK13272001A3 (en) |
TR (2) | TR200401779T2 (en) |
UA (1) | UA69449C2 (en) |
WO (1) | WO2000058295A2 (en) |
YU (1) | YU68601A (en) |
ZA (1) | ZA200107642B (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6686502B1 (en) * | 1999-03-26 | 2004-02-03 | Ucb S.A. | Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
PE20001566A1 (en) * | 1999-03-26 | 2001-02-05 | Ucb Sa | 1,4-SUBSTITUTED PIPERAZINES, 1,4-SUBSTITUTED PIPERIDINES AND 1-SUBSTITUTED 4-ALKYLIDENYL PIPERIDINES |
US6894059B1 (en) * | 1999-03-26 | 2005-05-17 | Ucb S.A. | Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
AU784813B2 (en) | 2000-01-17 | 2006-06-29 | Bayer Aktiengesellschaft | Substituted aryl ketones |
US6440994B1 (en) * | 2000-03-29 | 2002-08-27 | Richard J. Sanders, Jr. | Method of treating acne |
GB0009479D0 (en) * | 2000-04-17 | 2000-06-07 | Cipla Limited | Antihistaminic compounds |
AU2003231921B8 (en) * | 2002-03-27 | 2009-04-02 | Sun Pharma Advanced Research Company Limited | 4-(diarylmethyl)-1-piperazinyl derivatives |
US7381821B2 (en) | 2003-01-23 | 2008-06-03 | Ucb, S.A. | Piperazine derivatives and their use as synthesis intermediates |
EP1457485A1 (en) * | 2003-03-14 | 2004-09-15 | Dompé S.P.A. | Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
WO2006010283A1 (en) * | 2004-07-28 | 2006-02-02 | Universität Zürich | Prevention and treatment of thrombus formation |
KR100658436B1 (en) * | 2005-12-09 | 2006-12-27 | 한국화학연구원 | Compositions for external application, containing adenosylcobalamin for improvement of skin diseases |
WO2008001079A1 (en) * | 2006-06-27 | 2008-01-03 | Biolipox Ab | Methods for identifying modulators of eoxin formation |
MX2009004233A (en) | 2006-10-18 | 2009-08-12 | Pfizer Prod Inc | Biaryl ether urea compounds. |
CA2707305A1 (en) * | 2007-12-12 | 2009-06-18 | Amgen Inc. | Glycine transporter-1 inhibitors |
DK2123277T3 (en) * | 2007-12-18 | 2011-03-14 | Meiji Seika Kaisha | Preventive or therapeutic agent for inflammatory bowel disease |
WO2010046908A2 (en) | 2008-09-17 | 2010-04-29 | Calyx Chemicals And Pharmaceuticals Pvt. Ltd. | Novel water based process for the preparation of substituted diphenylmethyl piperazines |
CN102924406B (en) * | 2012-11-07 | 2014-11-05 | 南京医科大学 | Substituted aryl oxygen ethylpiperazine derivative, preparation method of substituted aryl oxygen ethylpiperazine derivative and application of substituted aryl oxygen ethylpiperazine derivative |
CN107602534B (en) * | 2017-09-05 | 2020-04-24 | 合肥医工医药股份有限公司 | Compound with anti-histamine and anti-inflammatory activity and preparation method and application thereof |
CN115215800B (en) * | 2021-04-21 | 2023-07-18 | 赣江中药创新中心 | Dibenzocyclyl-cyclic amino ether derivative or salt, and preparation method and application thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2898339A (en) | 1957-07-29 | 1959-08-04 | Wm S Merrell Co | N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine |
GB1574822A (en) | 1976-03-23 | 1980-09-10 | Lafon Labor | Acetohydroxamic acid derivatives and pharmaceutical compositions thereof |
US4282233B1 (en) * | 1980-06-19 | 2000-09-05 | Schering Corp | Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines |
DK154078C (en) * | 1981-02-06 | 1989-05-22 | Ucb Sa | METHOD OF ANALOGUE FOR THE PREPARATION OF 2- (2- (4- (DIPHENYL-METHYL) -1-PIPERAZINYL) ETHOXY) -ACETAMIDES OR ACID ADDITION SALTS. |
US5438062A (en) * | 1986-10-31 | 1995-08-01 | Schering Corporation | Benzo(5,6)cycloheptapyridines, compositions and methods of use |
US4826853A (en) | 1986-10-31 | 1989-05-02 | Schering Corporation | 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use |
US5066658A (en) * | 1988-11-10 | 1991-11-19 | Ortho Pharmaceutical Corporation | Substituted hydroxyureas |
US5288751A (en) * | 1992-11-06 | 1994-02-22 | Abbott Laboratories | [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis |
HUT76066A (en) | 1993-10-15 | 1997-06-30 | Schering Corp | Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases, pharmaceutical compositions containing them and process for producing them |
US5719148A (en) | 1993-10-15 | 1998-02-17 | Schering Corporation | Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
WO1995013264A1 (en) | 1993-11-08 | 1995-05-18 | Terumo Kabushiki Kaisha | Hydroxamic acid derivative and medicinal preparation containing the same |
US5877177A (en) | 1997-06-17 | 1999-03-02 | Schering Corporation | Carboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
US6894059B1 (en) * | 1999-03-26 | 2005-05-17 | Ucb S.A. | Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
US6686502B1 (en) * | 1999-03-26 | 2004-02-03 | Ucb S.A. | Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
PE20001566A1 (en) * | 1999-03-26 | 2001-02-05 | Ucb Sa | 1,4-SUBSTITUTED PIPERAZINES, 1,4-SUBSTITUTED PIPERIDINES AND 1-SUBSTITUTED 4-ALKYLIDENYL PIPERIDINES |
-
2000
- 2000-03-17 PE PE2000000236A patent/PE20001566A1/en not_active Application Discontinuation
- 2000-03-22 GT GT200000034A patent/GT200000034A/en unknown
- 2000-03-23 AR ARP000101298A patent/AR020026A1/en not_active Application Discontinuation
- 2000-03-23 AU AU34105/00A patent/AU761422B2/en not_active Ceased
- 2000-03-23 IL IL14548100A patent/IL145481A0/en unknown
- 2000-03-23 TR TR2004/01779T patent/TR200401779T2/en unknown
- 2000-03-23 BR BR0009341-6A patent/BR0009341A/en not_active IP Right Cessation
- 2000-03-23 WO PCT/BE2000/000026 patent/WO2000058295A2/en not_active Application Discontinuation
- 2000-03-23 CA CA002368090A patent/CA2368090A1/en not_active Abandoned
- 2000-03-23 CN CNA2004100282269A patent/CN1528742A/en active Pending
- 2000-03-23 EP EP00912274A patent/EP1165533B1/en not_active Expired - Lifetime
- 2000-03-23 TR TR2001/02717T patent/TR200102717T2/en unknown
- 2000-03-23 MX MXPA01009664A patent/MXPA01009664A/en active IP Right Grant
- 2000-03-23 ID IDW00200102070A patent/ID30430A/en unknown
- 2000-03-23 CN CNB008068216A patent/CN1160344C/en not_active Expired - Fee Related
- 2000-03-23 NZ NZ514291A patent/NZ514291A/en unknown
- 2000-03-23 DE DE60014876T patent/DE60014876T2/en not_active Expired - Fee Related
- 2000-03-23 ES ES00912274T patent/ES2231164T3/en not_active Expired - Lifetime
- 2000-03-23 YU YU68601A patent/YU68601A/en unknown
- 2000-03-23 CZ CZ20013471A patent/CZ20013471A3/en unknown
- 2000-03-23 KR KR1020017012282A patent/KR20020005635A/en not_active Application Discontinuation
- 2000-03-23 JP JP2000607998A patent/JP2002540198A/en not_active Withdrawn
- 2000-03-23 RU RU2001129098/04A patent/RU2241707C2/en not_active IP Right Cessation
- 2000-03-23 CN CNA2004100495405A patent/CN1560041A/en active Pending
- 2000-03-23 AT AT00912274T patent/ATE279401T1/en not_active IP Right Cessation
- 2000-03-23 EE EEP200400104A patent/EE200400104A/en unknown
- 2000-03-23 EE EEP200100498A patent/EE200100498A/en unknown
- 2000-03-23 SK SK1327-2001A patent/SK13272001A3/en unknown
- 2000-03-23 HU HU0200613A patent/HUP0200613A2/en unknown
- 2000-03-23 UA UA2001107287A patent/UA69449C2/en unknown
- 2000-03-23 PL PL00350845A patent/PL350845A1/en not_active Application Discontinuation
- 2000-03-24 PA PA20008493101A patent/PA8493101A1/en unknown
- 2000-03-24 CO CO00021428A patent/CO5180543A1/en not_active Application Discontinuation
- 2000-03-24 US US09/534,947 patent/US6451801B1/en not_active Expired - Fee Related
- 2000-03-25 DZ DZ000053A patent/DZ3027A1/en active
- 2000-03-27 JO JO200026A patent/JO2250B1/en active
-
2001
- 2001-09-17 ZA ZA200107642A patent/ZA200107642B/en unknown
- 2001-09-18 BG BG105909A patent/BG105909A/en unknown
- 2001-09-18 IS IS6077A patent/IS6077A/en unknown
- 2001-09-25 NO NO20014648A patent/NO20014648L/en not_active Application Discontinuation
-
2002
- 2002-05-11 HK HK02103566.6A patent/HK1041880B/en not_active IP Right Cessation
- 2002-09-12 US US10/242,346 patent/US6797713B2/en not_active Expired - Fee Related
-
2003
- 2003-08-08 US US10/637,163 patent/US20040048875A1/en not_active Abandoned
-
2004
- 2004-07-05 IS IS7343A patent/IS7343A/en unknown
- 2004-07-06 NO NO20042861A patent/NO20042861L/en not_active Application Discontinuation
- 2004-07-12 JP JP2004204939A patent/JP2005002118A/en not_active Withdrawn
- 2004-07-14 AR ARP040102477A patent/AR045991A2/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2001129098A (en) | Compounds and methods for treating asthma, allergies and inflammatory disorders | |
JP2008538109A5 (en) | ||
RU2361860C2 (en) | New substituted 3-sulphur-indoles | |
JP2010526025A5 (en) | ||
US6893650B1 (en) | N2-phenylamidine derivatives | |
RU2003131964A (en) | 4- (Phenyl-piperazinyl-methyl) -benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders | |
JP2005508293A5 (en) | ||
JP2006522035A5 (en) | ||
CA2463102A1 (en) | Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors | |
RU2006126978A (en) | 3- (4-BENZYLOXYPHENYL) PROPANIC ACID DERIVATIVES | |
JP2011518774A5 (en) | ||
AU782993B2 (en) | 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation | |
RU2241707C2 (en) | 1,4-substituted piperazines or 4-alkylidenyl piperidines, pharmaceutical composition based on thereof and method for treatment | |
JP2008524119A5 (en) | ||
RU2005111968A (en) | 4-pyrrolidinophenylbenzyl ether derivatives | |
RU2007103176A (en) | NEW ARILAMIDINE DERIVATIVE, ITS SALT AND ANTIFUNGER AGENT CONTAINING SUCH COMPOUNDS | |
US4330542A (en) | N(Sulfonyl)anilines for treating angina pectoris | |
RU2005111985A (en) | 4- (Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders | |
JP2022058610A5 (en) | ||
RU2007121222A (en) | GIDANTOIN DERIVATIVES USEFUL AS METALLOPROTEINASE INHIBITORS | |
RU2004138552A (en) | NITRO-OXY-DERIVATIVES OF CYCLOOXYGENASE-2 INHIBITORS | |
JP2007527416A5 (en) | ||
JP2007536320A5 (en) | ||
RU2005121662A (en) | DERIVATIVES OF (2-AMINOPHENYL) -AMIDE OF ARYLENE CARBIC ACID AS PHARMACEUTICAL DRUGS | |
JP2006508946A5 (en) |